District of Columbia Statutes
§ 48-833.01 — Requirement to disclose prescription drug marketing costs.
District of Columbia § 48-833.01
JurisdictionDistrict of Columbia
Title 48Foods and Drugs.
Ch. 8AAffordability of Prescription Drugs — AccessRx Program.
Subch. IIIFull Disclosure of Prescription Drug Marketing Costs.
This text of District of Columbia § 48-833.01 (Requirement to disclose prescription drug marketing costs.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
D.C. Code § 48-833.01 (2026).
Text
A manufacturer or labeler of prescription drugs dispensed in the District that employs, directs, or utilizes marketing representatives in the District shall report marketing costs for prescription drugs in the District. These marketing costs shall be reported to the Department for the purposes of assisting the District in its role as a purchaser of prescription drugs and as an administrator of prescription drug programs, enabling the District to determine the scope of prescription drug marketing costs and their effect on the cost, utilization, and delivery of health care services, and furthering the role of the District as guardian of the public interest.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
May 18, 2004, D.C. Law 15-164, § 301, 51 DCR 3688
Nearby Sections
15
§ 48-1001
Definitions.§ 48-1003
Notice of a drug free zone.§ 48-1004
Prohibition.§ 48-1005
Penalties.§ 48-1006
Reporting.§ 48-102
Definitions — “Drug”; “food”.§ 48-105
Complaints to be investigated.§ 48-108.01
Administrative remedies for enforcement.Cite This Page — Counsel Stack
Bluebook (online)
District of Columbia § 48-833.01, Counsel Stack Legal Research, https://law.counselstack.com/statute/dc/48-833.01.